Publicaciones en las que colabora con Carlos José Matute Almau (15)

2024

  1. A nonlinear meccano for Alzheimer's emergence by amyloid β-mediated glutamatergic hyperactivity

    Neurobiology of Disease, Vol. 194

  2. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer’s Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

2023

  1. Stimulation of synaptic activity promotes TFEB-mediated clearance of pathological MAPT/Tau in cellular and mouse models of tauopathies

    Autophagy, Vol. 19, Núm. 2, pp. 660-677

2022

  1. A Neuron, Microglia, and Astrocyte Triple Co-culture Model to Study Alzheimer’s Disease

    Frontiers in Aging Neuroscience, Vol. 14

  2. Amyloid β / PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer´s disease

    Cell Death and Disease, Vol. 13, Núm. 3

  3. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

  4. Linking Plasma Amyloid Beta and Neurofilament Light Chain to Intracortical Myelin Content in Cognitively Normal Older Adults

    Frontiers in Aging Neuroscience, Vol. 14

  5. Recombinant Integrin β1 Signal Peptide Blocks Gliosis Induced by Aβ Oligomers

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

2021

  1. Effects of platelet-rich plasma on cellular populations of the central nervous system: The influence of donor age

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-20

  2. Whole blood expression pattern of inflammation and redox genes in mild alzheimer’s disease

    Journal of Inflammation Research, Vol. 14, pp. 6085-6102

2019

  1. Corrigendum to "Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease"

    Mediators of inflammation

2018

  1. Contribution of neurons and glial cells to complement-mediated synapse removal during development, aging and in Alzheimer's disease

    Mediators of Inflammation, Vol. 2018

  2. Mangiferin and morin attenuate oxidative stress, mitochondrial dysfunction, and neurocytotoxicity, induced by Amyloid Beta Oligomers

    Oxidative Medicine and Cellular Longevity, Vol. 2018

  3. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis

    EMBO Molecular Medicine, Vol. 10, Núm. 8

  4. Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation

    Molecular Psychiatry, Vol. 23, Núm. 6, pp. 1530-1540